HSBC loses conviction in leading drugmaker, forecasts 'tough path' ahead
HSBC has stopped believing in AstraZeneca's stock. AstraZeneca is a big drug company. It made a mistake in a test for a heart disease.
6.2Significance
1 source7.0Source trust
HSBC
Connected entities
organizationAnalystsorganizationAstraZenecaorganizationAstraZeneca'sorganizationBritish-SwedishorganizationFororganizationIBMorganizationReduceorganizationSharesorganizationThey
Appears in 2 topic(s)
HSBC downgrades IBM to Reduce, says "synthetic IBM" offers better value
HSBC downgrades IBM to Reduce, says "synthetic IBM" offers better value
6.0Significance
1 source6.0Source trust